Liposomal drug delivery represents a highly adaptable therapeutic platform for treating a
wide range of diseases. Natural and synthetic lipids, as well as surfactants, are commonly …

Over the past decade, we have seen rapid advances in applying nanotechnology in
biomedical areas including bioimaging, biodetection, and drug delivery. As an emerging …

The rapid advancement of nanotechnology has raised the possibility of using engineered
nanoparticles that interact within biological environments for treatment of diseases …

Metastasis accounts for the vast majority of cancer deaths. The unique challenges for
treating metastases include their small size, high multiplicity and dispersion to diverse organ …

Among several promising new drug-delivery systems, liposomes represent an advanced
technology to deliver active molecules to the site of action, and at present several …

The review concentrates on the use of polymeric micelles as pharmaceutical carriers.
Micellization of biologically active substances is a general phenomenon that increases the …

Over the last decade, significant progress has been made in the field of drug delivery. The
advent of engineered nanoparticles has allowed us to circumvent the initial limitations to …

Injectable blood persistent particulate carriers have important therapeutic application in site-
specific drug delivery or medical imaging. However, injected particles are generally …

Over the last few decades, colloidal drug delivery systems (CDDS) such as nano-structures
have been developed in order to improve the efficiency and the specificity of drug action …

RNA interference (RNAi) is a specific gene‐silencing mechanism triggered by small
interfering RNA (siRNA). The application of RNAi in the clinic requires the development of …